Geneva – Ivermectin, as well as other repurposed and new products, has been under evaluation in clinical trials as a potential treatment for COVID-19. After updating the independent living network meta-analysis, the WHO Guidelines Development Group has updated the WHO Living Guidelines: Therapeutics and COVID-19 (today March 31).  In this updated version, WHO recommends not … Continue reading Unitaid statement regarding Ivermectin as a potential COVID-19 treatment